LENA M. NAPOLITANO, MD
Professor of Surgery
Division Chief, Acute Care Surgery
Associate Chair, Department of Surgery
Director, Trauma and Surgical Critical Care
University of Michigan Health System
Ann Arbor, Michigan
Lena M. Napolitano, MD, is Professor of Surgery and Chief of the Division of Acute Care Surgery [Trauma, Burns, Surgical Critical Care, and Emergency Surgery]. She also serves as Associate Chair for Critical Care within the Department of Surgery, Director of Trauma and Surgical Critical Care, and Program Director of the Surgical Critical Care Fellowship (7 fellows annually). Dr. Napolitano received her medical degree and completed her general surgery residency in 1990 at George Washington University School of Medicine, Washington, DC. Dr. Napolitano completed a fellowship in Surgical Critical Care and Trauma at the University of North Carolina and is board-certified in General Surgery and Surgical Critical Care.
Dr. Napolitano was previously Director of Surgical Critical Care and Co-Director of Trauma at the University of Massachusetts Medical Center from 1992 to 1995. She then joined the faculty at the University of Maryland, where she served as Director of Surgical Critical Care, Program Director of the Surgical Critical Care Fellowship, Associate Program Director of the General Surgery Residency Program, and Chief of the Division of Surgical Critical Care. In April of 2005, Dr. Napolitano joined the faculty of the University of Michigan Health Systems.
Dr. Napolitano's clinical interests include general surgery, trauma, and surgical critical care. Her research interests are in translational and outcomes research in trauma and surgical critical care, with a focus on multiple organ failure, systemic inflammatory response syndrome, anemia, and blood transfusion. She serves on the editorial board and as a reviewer for a number of surgical journals.
Philip S. Barie, MD, MBA
Professor of Surgery and Public Health
Chief, Division of Critical Care and Trauma
Weill Cornell Medical College
Chief, Preston A. (Pep) Wade Surgery Service
Chief, Trauma Service
Director, Anne and Max A. Cohen
Surgical Intensive Care Unit
New York-Presbyterian Hospital
Weill Cornell Medical Center
New York, New York
Philip S. Barie, MD, MBA, FCCM, FACS graduated from Boston University with simultaneously awarded Bachelor of Arts (cum laude) and Doctor of Medicine degrees in 1977. In 2003, Dr. Barie received a Master of Business Administration degree (with academic distinction) from Auburn University.
Dr. Barie trained in general surgery at The New York Hospital-Cornell Medical Center under the tutelage of G. Tom Shires, MD, who stimulated his interest in trauma and critical care. After receiving a National Institutes of Health (NIH) National Research Service Award Postdoctoral Fellowship in trauma and burn research at Albany Medical College, he joined the Cornell faculty in 1984.
Dr. Barie is a tenured Professor of Surgery and Public Health at Weill Cornell Medical College, Chief of the Division of Critical Care and Trauma, and Director of the Anne and Max A. Cohen Surgical Intensive Care Unit at New York-Presbyterian Hospital/Weill Cornell Medical Center. Dr. Barie is a Fellow of the American College of Surgeons, the American College of Critical Care Medicine, the American Surgical Association, the American Association for the Surgery of Trauma, and the Infectious Diseases Society of America, among the more than 25 societies to which he has been elected.
Dr. Barie is an active investigator in the epidemiology of multiple organ dysfunction syndrome, the host biologic response to infection, and the pharmacotherapy of sepsis. He has received the Peter C. Canizaro Award of The American Association for the Surgery of Trauma, the Best New Book Award of the Association of American Publishers (for the textbook Surgical Intensive Care), the Presidential Citation of the Society of Critical Care Medicine, the Distinguished Alumnus Award of Boston University School of Medicine, and is mentioned in Who’s Who in America. He is a Past-President of the Society of Critical Care Medicine, the Eastern Association for the Surgery of Trauma, the Surgical Infection Society, The Halsted Society, and The New York State Society of Surgeons.
Dr. Barie is the author or coauthor of more than 200 peer-reviewed manuscripts, 3 books, and nearly 90 book chapters. He is the editor of Surgical Infections, and serves on the editorial boards of several peer-reviewed journals, including Critical Care Medicine.
Donald E. Fry, MD
Executive Vice President for
Clinical Outcomes Management
Michael Pine and Associates
Adjunct Professor of Surgery
Northwestern University
Feinberg School of Medicine
Chicago, Illinois
Donald E. Fry, MD, was born in Marion, Ohio on August 16, 1946. He completed his Bachelor of Science degree cum laude and Phil Beta Kappa from the Ohio State University in 1968. He completed medical school at Ohio State University in 1972. After a surgical internship at the University of Texas-Southwestern Medical School in 1973, he completed his general surgery residency with Hiram C. Polk, Jr., MD, at the University of Louisville School of Medicine in 1977. Dr. Fry had his first faculty appointment as an Instructor of Surgery at the University of Louisville, was promoted to Assistant Professor in 1978, and then became Associate Professor in 1981. In 1982, Dr. Fry accepted the position of Professor of Surgery at Case Western Reserve University in Cleveland and Chief of Surgical Services at the Cleveland VA Medical Center. In 1987, he moved to Albuquerque, New Mexico, where he became Professor and Chairman of the Department of Surgery. He resigned the Chairmanship in 2004 and remained a Professor of Surgery at the University of New Mexico until October 2005. He is currently the Executive Vice President for Clinical Outcomes Management for Michael Pine and Associates of Chicago, Illinois.
Dr. Fry is the author of over 225 journal articles, over 110 book chapters, and 8 books. He has been the president of the Association of VA Surgeons, the Shock Society, and the Surgical Infection Society of North America. He is a member of 25 surgical societies including the American Surgical Association, the Society of University Surgeons, and the American Association for the Surgery of Trauma. He is a Fellow of the American College of Surgeons (ACS), and served on the Board of Governors of the ACS from 1998 to 2004. He is a Fellow of the Infectious Diseases Society of America. He received the Distinguished Alumni Award from the Ohio State University in 1997.
Dr. Fry has had a career interest in the areas of surgical infection, shock, multiple organ failure, the septic response, and complicated intra-abdominal surgery.
Reference List
Alvarado A. A practical score for the early diagnosis of acute appendicitis. Ann Emerg Med. May
1986;15(5):557-564.
Andersen BR, Kallehave FL, Andersen HK. Antibiotics versus placebo for prevention of postoperative
infection after appendicectomy. Cochrane Database Syst Rev. 2005(3):CD001439.
Apelqvist J, Bakker K, van I-Ioutum WH, Schaper NC. Practical guidelines on the management and
prevention of the diabetic foot: based upon the International Consensus on the Diabetic Foot (2007)
Prepared by the International Working Group on the Diabetic Foot. Diabetes Metab Res Rev. May-Jun
2008;24 Suppl 1:S181-187.
Avelox® (moxifloxacin hydrochloride) prescribing information. West Haven, Conn: Bayer Corporation;
July 2005. 2005; http://www.univgraph.com/bayer/inserts/Avelox.pdf
Babinchak T, Ellis-Grosse E, Dartois N, Rose GM, Loh E. The efficacy and safety of tigecycline for the
treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data. Clin Infect
Dis. Sep 1 2005 ;41(suppl 5):S354-S367.
Carvalho CB et al. Arq Bras Endocrinol Metabol. 2004;48:398-405.
Citron DM, Goldstein EJ, Merriam CV, Lipsky BA, Abramson MA. Bacteriology of moderate-to-severe
diabetic foot infections and in vitro activity of antimicrobial agents. J Clin Microbiol. Sep 2007;45
(9):2819-2828.
Cubicin® (daptomycin for injection) prescribing information. Lexington, MA: Cubist Pharmaceuticals,
Inc.; October 2007. 2007; http://www.cubicin.com/pdf/Prescribinglnformation.pdf. Accessed November
15, 2007.
Dang CN, Prasad YD, Boulton AJ, Jude EB. Methicillin-resistant Staphylococcus aureus in the diabetic
foot clinic: a worsening problem. Diabet Med. Feb 2003;20(2):159-161.
Hong JJ, Cohn SM, Ekeh AP, Newman M, Salama M, Leblang SD. A prospective randomized study of
clinical assessment versus computed tomography for the diagnosis of acute appendicitis. Surg Infect (Larchmt. Fall 2003;4(3):231-239.
Johnson JK, Khoie T, Shurland S, Kriesel K, Stine OC, Roghmann M. Skin and soft tissue infections
caused by methicillin-resistant Staphylococcus aureus USA300 clone. Emerg Infect Dis. 2007 ;13
(8):1195-1200.
Lipsky BA, ltani K, Norden C. Treating foot infections in diabetic patients: a randomized, multicenter,
open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate. Clin Infect Dis. Jan 1
2004;38(1):17-24.
Lipsky BA, Berendt AR, Deery HG, et al. Diagnosis and treatment of diabetic foot infections. Clin
Infect Dis. Oct 1 2004;39(7):885-910.
Lipsky BA, Holroyd KJ, Zasloff M. Topical versus systemic antimicrobial therapy for treating mildly
infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan
cream. Clin Infect Dis. Dec 15 2008;47(12):1537-1545.
Lipsky BA, Giordano P, Choudhri S, Song J. Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin-tazobactam/amoxicillin-clavulanate. J
Antimicrob Chemother. Aug 2007;60(2):370-376.
Lipsky BA, Armstrong DG, Citron DM, Tice AD, Morgenstem DE, Abramson MA. Ertapenem versus
piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled,
double-blinded, multicentre trial. Lancet. Nov 12 2005 ;366(9498): 1695-1703.
Lipsky BA. New developments in diagnosing and treating diabetic foot infections. Diabetes Metab Res
Rev. May-Jun 2008;24 Suppl 1:S66-71.
Lucasti C, J asovich A, Umeh O, Jiang J, Kaniga K, Friedland I. Efficacy and tolerability of IV
doripenem versus meropenem in adults With complicated intra-abdominal infection: a phase III,
prospective, multicenter, randomized, double-blind, noninferiority study; Clin Ther. May 2008;30
(5):868-883.
Malangoni MA, Song J, Herrington J, Choudhri S, Pertel P. Randomized controlled trial of
moxifloxacin compared with piperacillin-tazobactam and amoxicillin-clavulanate for the treatment of
complicated intra-abdominal infections. Ann Surg. Aug 2006 ;244(2):204-21 1.
Mazuski JE et al. Surg Infect (Larchmn. 2002;3(3):161-173.
Montravers P, Lepape A, Dubreuil L, et al. Clinical and microbiological profiles of community-acquired
and nosocomial intra-abdominal infections: results of the French prospective, observational EBIIA
study. J Antimicrob Chemother. Apr 2009;63(4):785-794.
Noel GJ, Bush K, Bagchi P, Ianus J, Strauss RS. A randomized, double-blind trial comparing
ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated
skin and skin-structure infections. Clin Infect Dis. Mar 1 2008 ;46(5):647-655.
Strauss RS, Bagchi P, Noel GJ, BAP00414 Study Group. Ceftobiprole (BPR) compared to vancomycin
plus ceftazidime (VAN +CAZ) in treatment of diabetic patients with mild, moderate and severe foot
infections [abstract 1086]. Paper presented at: 45th Annual Meeting of the Infectious Diseases Society
of America; October 4-7, 2007; Chicago, IL.
Raja NS. Microbiology of diabetic foot infections in a teaching hospital in Malaysia: a retrospective
study of 194 cases. J Microbiol Immunol Infect. Feb 2007;40(1):39-44.
Rossi F, Baquero F, Hsueh PR, et al. Invitro susceptibilities of aerobic and facultatively anaerobic
Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results
from SMART (Study for Monitoring Antimicrobial Resistance Trends). J Antimicrob Chemother. Jul
2006;58(1):205-210.
Sauerland S, Lefering R, Neugebauer EA. Laparoscopic versus open surgery for suspected appendicitis.
Cochrane Database Syst Rev. 2002(1):CD001546.
Solomkin JS, Mazuski JE, Baron EJ, et al. Guidelines for the selection of anti-infective agents for
complicated intra-abdominal infections. Clin Infect Dis. Oct 15 2003 ;37(8):997-1005.
Solomkin JS, Umeh O, Jiang J, Kaniga K, Friedland I. Doripenem vs. meropenem with an option for
oral step-down therapy in the treatment of complicated intra-abdominal infections [abstract L-487].
Paper presented at: 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy; September l7-20, 2007; Chicago, IL.
Sporn E, Petroski GF, Mancini GJ, Astudillo JA, Miedema BW, Thaler K. Laparoscopic appendectomy - is it worth the cost? Trend analysis in the US from 2000 to 2005. J Am Coll Surg. Feb 2009;208(2):l79- 185 el72.
Stanaway S, Johnson D, Moulik P, Gill G. Methicillin-resistant Staphylococcus aureus (MRSA) isolation from diabetic foot ulcers correlates with nasal MRSA carriage. Diabetes Res Clin Pract. Jan 2007;75(1):47-50.
Tentolouris N, Petrikkos G, Vallianou N, et al. Prevalence of methicillin-resistant Staphylococcus aureus in infected and uninfected diabetic foot ulcers. Clin Microbiol Infect. Feb 2006;12(2):186-189.
Tentolouris N, Jude EB, Smirnof I, Knowles EA, Boulton AJ. Metbicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic. Diabet Med. Sep 1999;16(9):767-771.
Tygacil® (tigecycline for injection) prescribing information. Philadelphia, PA: Wyeth Pharmaceuticals Inc.; May 2007. 2007; http://www.wyeth.com/content/showlabeling.asp?id=474. Accessed August 7, 2007.
van Randen A, Bipat S, Zwinderman AH, Ubbink DT, Stoker J, Boenneester MA. Acute appendicitis: meta-analysis of diagnostic performance of CT and graded compression US related to prevalence of disease. Radiology. Oct 2008;249(1):97-106.
Weigelt J, Itani K, Stevens D, Lau W, Dryden M, Knirsch C. Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections. Antimicrob Agents Chemother. Jun 2005 ;49(6):2260- 2266.
Wise SW, Labuski MR, Kasales CJ, et al. Comparative assessment of CT and sonographic techniques for appendiceal imaging. AJR Am J Roentgenol . Apr 2001 ;176(4):933-941.
This program is presented by the Surgical Infection Society and jointly sponsored by Penn State College of Medicine and SynerMed® Communications, supported by an educational grant from Ortho-McNeilTM, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., administered by Ortho-McNeil Janssen Scientific Affairs, LLC
Copyright 2009 © SynerMed Communications. All rights are reserved.
.......